AD
Teriparatide(CAS: 52232-67-4)
CAS Number
Related Products
Glucagon
CAS Number: 16941-32-5
Semaglutide
CAS Number: 910463-68-2
![1-{[(4R,7S,10S,13S,16S)-7-(2-Amino-2-oxoethyl)-10-(3-amino-3-oxopropyl)-13-benzyl-16-(4-hydroxybenzyl)-6,9,12,15,18-pentaoxo-1,2-dithia-5,8,11,14,17-pentaazacycloicosan-4-yl]carbonyl}-L-prolyl-L-argin
ylglycinamide](https://static.chemtradehub.com/structs/166/16679-58-6-794f.webp)
Abarelix
CAS Number: 183552-38-7
Bivalirudin
CAS Number: 128270-60-0
![[(3R,11S,17S,20S,25aS)-11-(4-Carbamimidamidobutyl)-3-carbamoyl-20-(1H-indol-3-ylmethyl)-1,9,12,15,18,21-hexaoxodocosahydro-7H-pyrrolo[2,1-g][1,2,5,8,11,14,17,20]dithiahexaazacyclotricosin-17-yl]acetic
acid](https://static.chemtradehub.com/structs/188/188627-80-7-15c6.webp)
Nesiritide
CAS Number: 124584-08-3
Other Suppliers for Teriparatide
Basic Information
Molecular Formula
C181H291N55O51S2
Molecular Weight
4118 g/mol
Chemical Identifiers
SMILES
CCC(C)C(C(=O)NC(CCC(=O)N)C(=O)NC(CC(C)C)C(=O)NC(CCSC)C(=O)NC(CC1=CNC=N1)C(=O)NC(CC(=O)N)C(=O)NC(CC(C)C)C(=O)NCC(=O)NC(CCCCN)C(=O)NC(CC2=CNC=N2)C(=O)NC(CC(C)C)C(=O)NC(CC(=O)N)C(=O)NC(CO)C(=O)NC(CCSC)C(=O)NC(CCC(=O)O)C(=O)NC(CCCNC(=N)N)C(=O)NC(C(C)C)C(=O)NC(CCC(=O)O)C(=O)NC(CC3=CNC4=CC=CC=C43)C(=O)NC(CC(C)C)C(=O)NC(CCCNC(=N)N)C(=O)NC(CCCCN)C(=O)NC(CCCCN)C(=O)NC(CC(C)C)C(=O)NC(CCC(=O)N)C(=O)NC(CC(=O)O)C(=O)NC(C(C)C)C(=O)NC(CC5=CNC=N5)C(=O)NC(CC(=O)N)C(=O)NC(CC6=CC=CC=C6)C(=O)O)NC(=O)C(CCC(=O)O)NC(=O)C(CO)NC(=O)C(C(C)C)NC(=O)C(CO)N
InChIKey
OGBMKVWORPGQRR-UHFFFAOYSA-N
Database References
MDL Number
MFCD00149013
FAQ
Teriparatide is a synthetic analog of parathyroid hormone (PTH), specifically designed to mimic the action of the naturally occurring hormone. Its chemical formula is C18H34N2O6S2. It is a peptide with a molecular weight of approximately 409.58 g/mol and is known for its ability to stimulate bone formation. Teriparatide is primarily used in the treatment of osteoporosis and is available as a prescription medication.
Teriparatide is mainly used for the treatment of osteoporosis, particularly in postmenopausal women and men with a high risk of fractures. It is also used in patients with osteogenesis imperfecta. In addition to its pharmaceutical applications, Teriparatide may be used in research settings for studying bone metabolism and as a tool for drug development related to bone health. Its use in industry is limited due to its specific biological function.
Teriparatide is generally considered safe when used as directed under medical supervision. However, it may cause side effects such as hypocalcemia, hypercalcemia, and changes in bone metabolism. Proper handling and administration are essential to ensure safety. It is important to follow safety guidelines and consult healthcare professionals for appropriate use and monitoring.
Teriparatide should be stored in a cool, dry place away from direct light. It is typically kept at a temperature between 2°C to 8°C (refrigerated) and should not be exposed to moisture or humidity. The medication should be stored in its original container to maintain stability and prevent degradation. Always check the manufacturer's instructions for specific storage requirements.
Safety Notice
Please verify product specifications and safety data before use. Contact the supplier for detailed safety information.
Always follow proper handling procedures
Contact Information
578615267@qq.com